Exploring diarylheptanoid derivatives to target LIMK1 as potential agents against colorectal cancer
{{output}}
LIMK1 has been demonstrated to be highly correlated with the progression and overall survival rates of colorectal cancer (CRC) patients. In this study, a series of diarylheptanoid scaffold derivatives were intentionally designed and synthesised to evaluate the... ...